MedTrace Logo

Prevalence of Rheumatic Heart Disease Among Pregnant Women in Kenya

NCT03411993 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 612

Last updated 2018-07-27

No results posted yet for this study

Summary

There is currently no routine screening for cardiac disease for pregnant women in areas of high prevalence. This study will aim to determine the point prevalence of cardiac disease in women presenting for antenatal care at Moi Teaching and Referral Hospital. More specifically, it will aim to use focused echocardiography as a screening tool to determine the prevalence of cardiac disease among pregnant women attending MTRH antenatal clinic.

Conditions

  • Cardiac Disease
  • Pregnancy Related

Interventions

DIAGNOSTIC_TEST

Focused cardiac echography

All pregnant women attending antenatal care will be eligible to undergo focused cardiac echo to identify underlying cardiac disease

Sponsors & Collaborators

  • Moi Teaching and Referral Hospital

    collaborator OTHER

  • Mount Sinai Hospital, Canada

    collaborator OTHER

  • Duke University

    collaborator OTHER

  • Mount Sinai Hospital, New York

    collaborator OTHER

  • Moi University

    lead OTHER

Principal Investigators

  • John Snelgrove, MD · University of Toronto

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-01-31
Primary Completion
2018-03-12
Completion
2018-03-12

Countries

  • Kenya

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03411993 on ClinicalTrials.gov